Elite Pharmaceuticals Inc (ELTP) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Elite Pharmaceuticals Inc   (ELTP)
 

Elite Pharmaceuticals Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELTP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) -17.52 % 7.99 % 8.07 % 9.17 %
Q / Q Revenue Growth (Q2 MRQ) -20.6 % 1.44 % 1.81 % 4.22 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 34.95 % 7.47 % 7.04 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) -4.67 % 4.22 % 3.51 % 2.08 %
Revenue 5 Year Average Growth 42.45 % 7.41 % 8.65 % 10.59 %


ELTP's Growth Comparisons in I. Quarter 2026




Elite Pharmaceuticals Inc 's sharp decrease of -17.52% in sales in the first quarter from the same quarter a year ago, those results deviated strongly from rising Revenue in Major Pharmaceutical Preparations industry with 7.99%, and underperformed the 8.07% Revenue growth in the Healthcare sector. Weak first quarter sales, in Major Pharmaceutical Preparations industry and within the Healthcare sector, were reflected in Elite Pharmaceuticals Inc results which underperformed overall market.

Comparing company's Revenue to the fourth quarter results, sales were lower by -20.6% . On the annual basis, average annual sales growth for Elite Pharmaceuticals Inc is 42.45%, while S & P 500's including only Businesses with the first quarter 2026 results, average yearly sales growth is 10.59% over the past five years.

ELTP Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Scheduled Products Licensing Fees
-
-52.58 %
Direct Sales to Wholesalers
-
-74.87 %
Indirect Sales to Wholesalers
-
-80.94 %
Abbreviated New Drug Applications Revenue
-
-
Scheduled Products Manufacturing Fees
-
-80.34 %
Un Scheduled Products Manufacturing Fees
-
-31.83 %
Total
-17.52 %
-20.6 %


Growth Rates of ELTP's Income in the first quarter 2026


ELTP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) -65.3 % 53.67 % 27.58 % 29.95 %
Sequential Operating Income Change (Q2 MRQ) -26.09 % -27.23 % -17.34 % 4.5 %
Y / Y Operating Income Growth (Q2 TTM) -6.66 % 48 % 37.03 % 14.37 %
Sequential Operating Income Growth (Q2 TTM) -28.85 % 13.44 % 9.74 % 6.96 %
Operating Income 5 Year Avg. Change 87.76 % 14.39 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - - - 21.83 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) -73.64 % - - 11.13 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - -59.4 % -25.13 % 16.46 %
Sequential Income from Cont. Ops. Change (Q2 TTM) 24.15 % -10.61 % -6.43 % 6.05 %
Income from Cont. Ops. 5 Year Avg. Change 54.55 % -0.55 % 0.17 % -28.52 %

ELTP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - -26.27 % 16.75 % 21.56 %
Q / Q Net Income Growth (Q2 MRQ) -67.98 % -43.4 % -34.6 % 11.12 %
Y / Y Net Income Change (Q2 TTM) - 27.23 % 32.74 % 16.59 %
Sequential Net Income Change (Q2 TTM) 26.29 % 3.41 % 7.31 % 6.03 %
Net Income 5 Year Avg. Growth 54.55 % 14.55 % 9.21 % 22.96 %

ELTP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - - - 21.83 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) -50 % - - 11.13 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) 50 % - - -99.7 %
EPS from Cont. Ops. 5 Year Avg. Growth 31.95 % -10.78 % 0.17 % -28.52 %



ELTP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - -29.53 % 16.75 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) -50 % -32.44 % -34.6 % 11.12 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - -99.97 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) 66.67 % - - -99.87 %
EPS Net 5 Year Avg. Change 24.57 % 14.55 % 9.21 % 22.96 %



Elite Pharmaceuticals Inc reported bottom-line of $ 0.01 in the first quarter, compare to $ -0.01 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -29.53%, while Healthcare sector increased by 16.75%, and overall market improved by 21.56%.

Bottom-line fell by -50% from the fourth quarter results. Comparing the annual growth, income per share of 24.57% on average in last five years, to the S & P 500's, including only Businesses with the first quarter 2026 earnings, average yearly income per share growth is 22.96%. Elite Pharmaceuticals Inc grew faster than the market.

ELTP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) -36.39 % -15.03 % -10.43 % 2 %
Sequential Free Cash Flow Change (Q2 MRQ) 1.25 % -44.18 % -28.82 % 22.32 %
Y / Y Free Cash Flow Change (Q2 TTM) -0.55 % 9.6 % 11.09 % 11.81 %
Sequential Free Cash Flow Change (Q2 TTM) -22.81 % 1.75 % 1.93 % 2.41 %
Free Cash Flow 5 Year Avg. Change 50.75 % 1.86 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - -90.24 % 1035.72 %
Sequential Net Cash Flow Change (Q2 MRQ) - - -99.01 % -
Y / Y Net Cash Flow Change (Q2 TTM) - -21.47 % -23.28 % -
Sequential Net Cash Flow Change (Q2 TTM) - -44.21 % -25.11 % -
Net Cash Flow 5 Year Avg. Change 55.1 % 29.88 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 270.75 % 19.29 % 9.45 % 23.41 %
Sequential Capital Expenditures Change (Q2 MRQ) -49.42 % 20.61 % 18.78 % 18.97 %
Y / Y Capital Expenditures Change (Q2 TTM) 34.15 % 20.54 % 10.57 % 23.88 %
Sequential Capital Expenditures Change (Q2 TTM) 27.77 % 11.3 % 6.56 % 7.02 %
Capital Expenditures 5 Year Avg. Change 22.91 % 8.82 % 9.12 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.